Issue Date: December 15, 2014
Confronting Irreproducibility In Life Sciences Research
Reproducibility is a hallmark of science—at least, it’s supposed to be. Over the past several years, it’s become increasingly apparent that many lab studies, especially in the life sciences, are not reproducible. As a result, many putative drug targets or diagnostic biomarkers can’t be validated. Some estimates suggest that more than 50% of all published life sciences research is irreproducible, and some indicate that the figure might be even higher.
The problem flew below the . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society